1. Home
  2. RANI vs AQMS Comparison

RANI vs AQMS Comparison

Compare RANI & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • AQMS
  • Stock Information
  • Founded
  • RANI 2012
  • AQMS 2014
  • Country
  • RANI United States
  • AQMS United States
  • Employees
  • RANI N/A
  • AQMS N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • AQMS Metal Fabrications
  • Sector
  • RANI Health Care
  • AQMS Industrials
  • Exchange
  • RANI Nasdaq
  • AQMS Nasdaq
  • Market Cap
  • RANI 24.2M
  • AQMS 24.2M
  • IPO Year
  • RANI 2021
  • AQMS 2015
  • Fundamental
  • Price
  • RANI $2.12
  • AQMS $8.31
  • Analyst Decision
  • RANI Strong Buy
  • AQMS Buy
  • Analyst Count
  • RANI 6
  • AQMS 1
  • Target Price
  • RANI $8.67
  • AQMS $12.00
  • AVG Volume (30 Days)
  • RANI 44.1M
  • AQMS 3.9M
  • Earning Date
  • RANI 11-13-2025
  • AQMS 11-13-2025
  • Dividend Yield
  • RANI N/A
  • AQMS N/A
  • EPS Growth
  • RANI N/A
  • AQMS N/A
  • EPS
  • RANI N/A
  • AQMS N/A
  • Revenue
  • RANI $1,200,000.00
  • AQMS N/A
  • Revenue This Year
  • RANI N/A
  • AQMS N/A
  • Revenue Next Year
  • RANI N/A
  • AQMS $550.00
  • P/E Ratio
  • RANI N/A
  • AQMS N/A
  • Revenue Growth
  • RANI N/A
  • AQMS N/A
  • 52 Week Low
  • RANI $0.39
  • AQMS $3.37
  • 52 Week High
  • RANI $3.87
  • AQMS $39.40
  • Technical
  • Relative Strength Index (RSI)
  • RANI 65.39
  • AQMS 48.97
  • Support Level
  • RANI $1.76
  • AQMS $9.00
  • Resistance Level
  • RANI $3.87
  • AQMS $10.48
  • Average True Range (ATR)
  • RANI 0.45
  • AQMS 4.55
  • MACD
  • RANI 0.14
  • AQMS -0.60
  • Stochastic Oscillator
  • RANI 45.98
  • AQMS 10.20

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: